Sotatercept

Tax included
Sotatercept (ACE-011) is a soluble activin receptor 2A (ACVR2A) type IgG Fc fusion protein. Sotatercept combines activin and growth differentiation factor to try to restore the balance between growth promotion and growth inhibition signal pathways. Sotatercept has potential application in pulmonary arterial hypertension, anemia, bone loss, erythropoiesis, multiple myeloma (MM) osteolytic lesions.
MedChemExpress 
HY-P99590

Data sheet

Size
Multiple sizes
Reactivity
TGF-β Receptor
Application
COVID-19-immunoregulation
CAS
1001080-50-7